Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study. (March 2020)
- Record Type:
- Journal Article
- Title:
- Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study. (March 2020)
- Main Title:
- Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study
- Authors:
- Moh, Angela Mei Chung
Pek, Sharon Li Ting
Liu, Jianjun
Wang, Jiexun
Subramaniam, Tavintharan
Ang, Keven
Sum, Chee Fang
Kwan, Pek Yee
Lee, Simon Biing Ming
Tang, Wern Ee
Lim, Su Chi - Abstract:
- Highlights: Poor glycaemic control is associated with elevated risk for vascular complications. Biomarkers for predicting susceptibility to glycaemic deterioration are lacking. Osteoprotegerin (OPG) predicted development of poorly-controlled type 2 diabetes. OPG was independently associated with progression of albuminuria. OPG–albuminuria progression association was mediated by poorly-controlled diabetes. Abstract: Aims: Poor glycaemic control elevates the risk for vascular complications. Biomarkers for predicting susceptibility to glycaemic worsening are lacking. This 3-year prospective analysis assessed the utility of several circulating diabetes-related biomarkers for predicting loss of glycaemic control, and their contribution to albuminuria progression in type 2 diabetes mellitus (T2DM). Methods: T2DM subjects with adequately-controlled diabetes (HbA1c < 8%) at initial recruitment were analysed (N = 859). Baseline plasma levels of osteoprotegerin (OPG), C-reactive protein (CRP), adiponectin, intercellular-cell adhesion molecule-1, and vascular-cell adhesion molecule-1 were quantified using immunoassay. Definitions for development of uncontrolled diabetes and albuminuria progression were HbA1c ≥ 8.0% and increase in albuminuria category at follow-up, respectively. Results: At follow-up, 185 subjects developed uncontrolled diabetes. Higher baseline CRP and OPG levels were observed in the high-risk individuals, and predicted increased risk for developing uncontrolledHighlights: Poor glycaemic control is associated with elevated risk for vascular complications. Biomarkers for predicting susceptibility to glycaemic deterioration are lacking. Osteoprotegerin (OPG) predicted development of poorly-controlled type 2 diabetes. OPG was independently associated with progression of albuminuria. OPG–albuminuria progression association was mediated by poorly-controlled diabetes. Abstract: Aims: Poor glycaemic control elevates the risk for vascular complications. Biomarkers for predicting susceptibility to glycaemic worsening are lacking. This 3-year prospective analysis assessed the utility of several circulating diabetes-related biomarkers for predicting loss of glycaemic control, and their contribution to albuminuria progression in type 2 diabetes mellitus (T2DM). Methods: T2DM subjects with adequately-controlled diabetes (HbA1c < 8%) at initial recruitment were analysed (N = 859). Baseline plasma levels of osteoprotegerin (OPG), C-reactive protein (CRP), adiponectin, intercellular-cell adhesion molecule-1, and vascular-cell adhesion molecule-1 were quantified using immunoassay. Definitions for development of uncontrolled diabetes and albuminuria progression were HbA1c ≥ 8.0% and increase in albuminuria category at follow-up, respectively. Results: At follow-up, 185 subjects developed uncontrolled diabetes. Higher baseline CRP and OPG levels were observed in the high-risk individuals, and predicted increased risk for developing uncontrolled diabetes. OPG, but not CRP, was associated with albuminuria progression after multivariable adjustment. The relationship was attenuated following adjustment for development of uncontrolled diabetes, which emerged as a significant associate. Mediation analysis revealed that loss of glycaemic control explained 64.5% of the relationship between OPG and albuminuria progression. Conclusions: OPG outperformed other diabetes-related biomarkers to be a potentially useful biomarker for predicting loss of glycaemic control and its associated albuminuria deterioration. … (more)
- Is Part Of:
- Diabetes research and clinical practice. Volume 161(2020)
- Journal:
- Diabetes research and clinical practice
- Issue:
- Volume 161(2020)
- Issue Display:
- Volume 161, Issue 2020 (2020)
- Year:
- 2020
- Volume:
- 161
- Issue:
- 2020
- Issue Sort Value:
- 2020-0161-2020-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-03
- Subjects:
- Type 2 diabetes mellitus -- Hyperglycaemia -- Albuminuria -- Osteoprotegerin
Diabetes -- Periodicals
Diabetes Mellitus -- Periodicals
616.462 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01688227 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01688227 ↗
http://www.sciencedirect.com/science/journal/01688227 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.diabres.2019.107992 ↗
- Languages:
- English
- ISSNs:
- 0168-8227
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3579.603700
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13387.xml